ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000248690.2	Ponatinib	Bladder urothelial carcinoma	0.045896742	Resistant
ENSG00000248690.2	Ponatinib	Breast invasive carcinoma	0.029660188	Sensitive